Literature DB >> 12686038

Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak.

Katie Ewer1, Jonathan Deeks, Lydia Alvarez, Gerry Bryant, Sue Waller, Peter Andersen, Philip Monk, Ajit Lalvani.   

Abstract

BACKGROUND: The diagnosis of latent tuberculosis infection relies on the tuberculin skin test (TST), which has many drawbacks. However, to find out whether new tests are better than TST is difficult because of the lack of a gold standard test for latent infection. We developed and assessed a sensitive enzyme-linked immunospot (ELISPOT) assay to detect T cells specific for Mycobacterium tuberculosis antigens that are absent from Mycobacterium bovis BCG and most environmental mycobacteria. We postulated that if the ELISPOT is a more accurate test of latent infection than TST, it should correlate better with degree of exposure to M tuberculosis.
METHODS: A large tuberculosis outbreak in a UK school resulted from one infectious index case. We tested 535 students for M tuberculosis infection with TST and ELISPOT. We compared the correlation of these tests with degree of exposure to the index case and BCG vaccination.
FINDINGS: Although agreement between the tests was high (89% concordance, kappa=0.72, p<0.0001), ELISPOT correlated significantly more closely with M tuberculosis exposure than did TST on the basis of measures of proximity (p=0.03) and duration of exposure (p=0.007) to the index case. TST was significantly more likely to be positive in BCG-vaccinated than in non-vaccinated students (p=0.002), whereas ELISPOT results were not associated with BCG vaccination (p=0.44).
INTERPRETATION: ELISPOT offers a more accurate approach than TST for identification of individuals who have latent tuberculosis infection and could improve tuberculosis control by more precise targeting of preventive treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12686038     DOI: 10.1016/S0140-6736(03)12950-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  171 in total

1.  Evaluation of a tuberculosis whole-blood interferon-γ chemiluminescent immunoassay among Chinese military recruits.

Authors:  Xueqiong Wu; Ying Hou; Yan Liang; Junxian Zhang; Yourong Yang; Lan Wang; Chuiying Zhang
Journal:  Mol Diagn Ther       Date:  2011-12-01       Impact factor: 4.074

2.  Gamma interferon-based immunodiagnosis of tuberculosis: comparison between whole-blood and enzyme-linked immunospot methods.

Authors:  Elisabeth Schölvinck; Katalin A Wilkinson; Adam O Whelan; Adrian R Martineau; Michael Levin; Robert J Wilkinson
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

Review 3.  Practical aspects of the management of pericardial disease.

Authors:  Bernhard Maisch; Arsen D Ristić
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

4.  Latent tuberculosis infection screening for laboratory personnel using interferon-γ release assay and tuberculin skin test in Korea: an intermediate incidence setting.

Authors:  Hee-Won Moon; Hanah Kim; Mina Hur; Yeo-Min Yun; Anna Lee
Journal:  J Clin Lab Anal       Date:  2011-11       Impact factor: 2.352

Review 5.  Recent advances in testing for latent TB.

Authors:  Neil W Schluger; Joseph Burzynski
Journal:  Chest       Date:  2010-12       Impact factor: 9.410

Review 6.  Update on opportunistic infections in the era of effective antiretroviral therapy.

Authors:  Brian C Zanoni; Rajesh T Gandhi
Journal:  Infect Dis Clin North Am       Date:  2014-09       Impact factor: 5.982

7.  Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment.

Authors:  Sonia Mínguez; Irene Latorre; Lourdes Mateo; Alicia Lacoma; Jéssica Diaz; Alejandro Olivé; Jose Domínguez
Journal:  Clin Rheumatol       Date:  2012-01-21       Impact factor: 2.980

8.  Diagnostic Accuracy of Interferon Gamma-Induced Protein 10 mRNA Release Assay for Tuberculosis.

Authors:  Thomas Blauenfeldt; Raquel Villar-Hernández; Esther García-García; Irene Latorre; Line Lindebo Holm; Beatriz Muriel-Moreno; Maria Luiza De Souza-Galvão; Joan Pau Millet; Fina Sabriá; Adrián Sánchez-Montalva; Juan Ruiz-Manzano; Jose Pilarte; María A Jiménez; Carmen Centeno; Carmen Torres; Israel Molina-Pinargote; Yoel D González-Díaz; Javier Santiago; Adela Cantos; Cristina Prat; Peter Andersen; Jose Domínguez; Morten Ruhwald
Journal:  J Clin Microbiol       Date:  2020-09-22       Impact factor: 5.948

Review 9.  Newer diagnostic modalities for tuberculosis.

Authors:  Rakesh Lodha; S K Kabra
Journal:  Indian J Pediatr       Date:  2004-03       Impact factor: 1.967

10.  Performance of an interferon-gamma release assay for diagnosing latent tuberculosis infection in children.

Authors:  K Okada; T E Mao; T Mori; T Miura; T Sugiyama; T Yoshiyama; S Mitarai; I Onozaki; N Harada; S Saint; K S Kong; Y M Chhour
Journal:  Epidemiol Infect       Date:  2007-11-08       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.